StockData
Teva Pharmaceutical Industries Ltd logo

Teva Pharmaceutical Industries Ltd

TEVANYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/30
$41.31−0.19 (-0.46%)

Close on Oct 19, 2026Market cap $48.13BP/E 68.9Yield –

Teva Pharmaceutical Industries Anda Distribution by Quarter

Anda Distribution — Reported Within Legacy North America Segment (FY2016–FY2023) ($M)

Teva Pharmaceutical Industries Anda Distribution: $394M in Q4 2023, down 12.4% from a year earlier. No newer figure appears in the documents we track.

Latest, Q4 2023
394
Period ended Dec 31, 2023
Change on a year earlier
-12.4%
450 in Q4 2022
History
24 quarters
Since Q4 2017
Sources
19
Documents cited below

Where the Q4 2023 figure comes from

Calculated from reported figures: Q4 = full year (10-K) − nine months (10-Q)

Source: SEC Form 10-K (0001193125-24-031005) ↗

Reported in SEC Form 10-K / Form 10-Q (XBRL & Footnotes).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedAnda Distribution — Reported Within Legacy North America Segment (FY2016–FY2023) ($M)Year on yearSource
Q4 2023Dec 31, 2023394-12.4%SEC Form 10-K (0001193125-24-031005) ↗
Q3 2023Sep 30, 2023367-1.1%SEC Form 10-Q (0001193125-23-274495) ↗
Q2 2023Jun 30, 2023392+27.3%SEC Form 10-Q (0001193125-23-201707) ↗
Q1 2023Mar 31, 2023424+24.0%SEC Form 10-Q (0001193125-23-140697) ↗
Q4 2022Dec 31, 2022450+26.8%SEC Form 10-K (0001193125-24-031005) ↗
Q3 2022Sep 30, 2022371+2.2%SEC Form 10-Q (0001193125-23-274495) ↗
Q2 2022Jun 30, 2022308-2.5%SEC Form 10-Q (0001193125-23-201707) ↗
Q1 2022Mar 31, 2022342+18.3%SEC Form 10-Q (0001193125-23-140697) ↗
Q4 2021Dec 31, 2021355+10.6%SEC Form 10-K (0001193125-24-031005) ↗
Q3 2021Sep 30, 2021363+6.5%SEC Form 10-Q (0001193125-22-276883) ↗
Q2 2021Jun 30, 2021316-15.5%SEC Form 10-Q (0001193125-22-203392) ↗
Q1 2021Mar 31, 2021289-32.2%SEC Form 10-Q (0001193125-22-138669) ↗
Q4 2020Dec 31, 2020321-22.1%SEC Form 10-K (0001193125-23-031250) ↗
Q3 2020Sep 30, 2020341-2.8%SEC Form 10-Q (0001193125-21-308672) ↗
Q2 2020Jun 30, 2020374+6.6%SEC Form 10-Q (0001193125-21-227389) ↗
Q1 2020Mar 31, 2020426+12.4%SEC Form 10-Q (0001193125-21-136842) ↗

Cite this data

StockData. (2026). Teva Pharmaceutical Industries Anda Distribution ($M), quarterly Q4 2017–Q4 2023 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/sub-anda-us-legacy

See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?